p53
VC Fund
Stavanger, Norway
p53 is a VC fund in Stavanger focused on Biotechnology and Medical. p53 identifies and invests in innovative healthcare companies, particularly in the fields of biotechnology and medical devices.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries p53 invests in
Stages p53 invests in
Countries p53 invests in
Round sizes
Round size
- Series A
- $30M–$81M
Investment Focus
Industry
- Biotechnology 2 (67%)
- Medical 1 (33%)
- Life Science 1 (33%)
- Pharmaceutical 1 (33%)
Country
- Norway 1 (33%)
- Denmark 1 (33%)
- The Netherlands 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| RougeTx is a Netherlands-based biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction. Its lead candidate, RTX-001, targets hereditary haemorrhagic telangiectasia (HHT), an inherited disorder involving fragile blood vessels and recurrent bleeding. | $58M / Series A / Oct 06, 2026 | ||
| Calluna has developed a robust pipeline of selective antibodies, targeting immunological diseases. These include novel therapeutic candidates that fulfill unmet clinical needs across a spectrum of diseases. | $81.4M / Series A / Jan 23, 2024 | ||
| Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark. | $30M / Series A / Mar 14, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does p53 invest in?
p53 invests primarily in Biotechnology, Medical and Life Science startups, most often at Series A stage. Most of the 3 investments tracked by Shizune back companies in Norway. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does p53 invest in?
p53 typically joins rounds of $30M–$81M at Series A. These are whole funding-round sizes, not p53's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds p53 took part in.
When did p53 last invest?
The most recent investment recorded for p53 closed in Oct 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
